Legal & General Group PLC Annexon, Inc. Transaction History
Legal & General Group PLC
- $431 Billion
- Q3 2025
A detailed history of Legal & General Group PLC transactions in Annexon, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 8,476 shares of ANNX stock, worth $24,241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,476
Previous 8,476
-0.0%
Holding current value
$24,241
Previous $20,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
101MCall Options Held
88.6KPut Options Held
32.5K-
Satter Management Co., L.P.7.41MShares$21.2 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$20 Million1.13% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$18 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.84MShares$16.7 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $136M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...